Shares of Moderna fell 7.94% to $115.88 at 09:39 EST on Wednesday, after two consecutive sessions in a row of losses. The Nasdaq Stock Market is rising 0.51% to $12,807.90, after two successive sessions in a row of losses. This seems, as yet, a somewhat positive trend exchanging session today.
Moderna's last close was $138.30, 54.04% below its 52-week high of $178.50.
Moderna's Sales
Moderna's sales growth is 1841.7% for the present quarter and 19117.5% for the next. The company's growth estimates for the current quarter is a negative 2.7% and positive 660% for the next.
Moderna's Revenue
Year-on-year quarterly revenue growth grew by 826.4%, now sitting on 246.7M for the twelve trailing months.
Moderna's Stock Yearly Top and Bottom Value
Moderna's stock is valued at $115.88 at 09:39 EST, way below its 52-week high of $178.50 and way higher than its 52-week low of $17.68.
Moderna's Moving Average
Moderna's worth is under its 50-day moving average of $116.47 and way above its 200-day moving average of $80.87.Previous days news about Moderna
Philippines to start vaccine talks with Moderna by year-end: CNN. According to Bloomberg Quint on Mon Dec 21, "The Philippines will start talks with Moderna Inc. on or before Dec. 30 to secure supply of the company's coronavirus vaccine, Foreign Affairs Secretary Teodoro Locsin said Monday.", ""Moderna is interested in giving an allocation," he said in a live-streamed interview with CNN Philippines, citing Philippine ambassador to the U.S. Jose Manuel Romualdez."
Moderna, biontech post worst day for vaccine stocks in a month. According to Bloomberg Quint on Tue Dec 22, "Moderna, BioNTech and Pfizer have each traded off their highs since their vaccines received regulatory clearance.", "Moderna Inc. and BioNTech SE both fell more than 9% in heavy volume as the vaccine makers saw their worst day in the stock market since late November."